Paper - WANFANG MED ONLINE

You Position: Home > Paper

Role of Wnt/β-catenin signaling pathway in occurrence and development of hepatocellular carcinoma

( views:16, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 4

DOI:: 10.11569/wcjd.v29.i4.190

Key Word:: 肝癌;进展;Wnt/β-catenin信号通路

Abstract：已有研究表明肝癌的发生发展与多种信号通路有关.其中,Wnt配体/β-连环蛋白(Wnt/β-catenin)信号通路参与肝脏疾病进展的所有阶段,从最初的肝损伤到炎症、纤维化、肝硬化以及肿瘤的发生及进展均有所参与.异常的Wnt/β-catenin信号会促进包括癌症在内的不同肝脏疾病的发生和进展.在这篇综述中,我们将在介绍Wnt/β-catenin信号通路的激活、生物学功能及调控机制的基础上,讨论Wnt/β-catenin信号通路在肝癌的发生和进展的中的作用,并将对目前小分子抑制剂、中药提取物及微小RNAs(microRNAs,miRNAs)等能够抑制Wnt/β-catenin信号通路的相关因子进行阐述,为肝癌的基础与临床研究提供参考.

Reference

[1]曹聪,黄桂柳,黄赞松,等.miR-181a与消化系统常见肿瘤关系的研究进展[J].2017,(3).
[2]黎梨,邓凤莲,黄赞松,等.长链非编码RNA-H19调控人肝癌HepG2细胞增殖与凋亡[J].2019,(1).
[3]黄桂柳,冯巍巍,黄赞松,等.苦参素通过线粒体凋亡通路影响肝癌耐药细胞株HepG2/ADM化学治疗的耐药性[J].2019,(3).
[4]黎梨,廖俊,黄赞松.LncRNA调控常见肿瘤的研究进展[J].2018,(6).
[5]胡静,周喜汉,胡高裕,等.苦参素联合顺铂对实验性肝癌miR-21、miR-122表达的影响[J].2017,(21).
[6]廖俊,张彩灵,黄赞松,等.苦参素及Mir-181 a对人肝癌细胞耐药株H epG2/ADM裸鼠移植瘤中耐药蛋白P-gp的影响[J].2020,(1).
[7]黄赞松,向发良,周喜汉,等.苦参素对肝癌细胞HepG2细胞增殖和MicroRNA-122、MicroRNA-21表达的影响[J].2014,(11).
[8]郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].2019,(1).
[9]陈椿,杨哲,黄赞松.细胞信号转导通路与肝癌相关性研究进展[J].2019,27(21).
[10]X-H, Xia,C-J, Xiao,H, Shan.Facilitation of liver cancer SMCC7721 cell aging by sirtuin 4 via inhibiting JAK2/STAT3 signal pathway.[J].2017,21(6).
[11]Jingbo Pan,Zhaorui Lian,Sarah Wallet.The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor α-mediated apoptosis by activation of phosphoinositol 3-kinase and β-catenin[J].2007,88(12).
[12]Guo, Zongbing,Zhou, Yanmei,Yang, Jiping,etc.Dendrobium candidum extract inhibits proliferation and induces apoptosis of liver cancer cells by inactivating Wnt/beta-catenin signaling pathway[J].2019,110.
[13]Hua, Guo,Guowen, Hu,Qing, Yang,etc.Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.[J].2016,(49).
[14]Roberto, Gedaly,Roberto, Galuppo,Michael F, Daily,etc.Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535.[J].2014,9(6).
[15]Guo, Yuntao,Chen, Liwen,Sun, Chengyi,etc.MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/b-catenin signaling pathway[J].2017,91.
[16].Cyr61/CCN1 Is Regulated by Wnt/β-Catenin Signaling and Plays an Important Role in the Progression of Hepatocellular Carcinoma.[J].2012,7(4).
[17]Hongzhang, Cui,Ruijin, Song,Ju, Wu,etc.MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2.[J].2018,8(3).
[18]Zhaoxia,Hu,Peipei,Wang,Jiaxin,Lin,etc.MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.[J].2018,51(1).
[19]Carolin,Czauderna,Darko,Castven,Friederike L,Mahn,etc.Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer-from Tumor Development to Therapeutic Implications.[J].2019,11(8).
[20]Giovane G. Tortelote,Renata R. Reis,Fabio de Almeida Mendes,etc.Complexity of the Wnt/β-catenin pathway: Searching for an activation model[J].2017,40.
[21]Wang, Wenhui,Pan, Qiuwei,Fuhler, Gwenny M.,etc.Action and function of Wnt/beta-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma[J].2017,52(4).
[22]Yu, Hongxiu,Shen, Huali,Zhang, Yang,etc.CAV1 Promotes HCC Cell Progression and Metastasis through Wnt/β-Catenin Pathway.[J].2014,9(9).
[23]Jinping,Bai,Yingchun,Gao,Yanhui,Du,etc.MicroRNA-300 inhibits the growth of hepatocellular carcinoma cells by downregulating CREPT/Wnt/β-catenin signaling.[J].2019,18(4).
[24]Bowen,Yao,Yazhao,Li,Liang,Wang,etc.MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.[J].2019,47(1).
[25]Fu, Xiaomin,Zhu, Xiaoyan,Qin, Fujun,etc.Linc00210 drives Wnt/��-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner.[J].2018,17.
[26]Satdarshan Pal Monga.β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis[J].2015,148(7).
[27]Maria J Perugorria,Paula Olaizola,Ibone Labiano,etc.Wnt-β-catenin signalling in liver development, health and disease.[J].2019,16(2).
[28]Zhiyun, Zheng,Jimin, Liu,Zhe, Yang,etc.MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway.[J].2016,(19).
[29]Zhang,Y.,Liu,C.,Duan,X.,etc.CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling[J].2014,289(33).
[30].Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/β-Catenin signaling[J].2013,58(2).
[31]Miao Huang,Shengming Wu,Qiping Hu,etc.Agkihpin, a novel SVAE may inhibit the migration and invasion of liver cancer cells associated with the inversion of EMT induced by Wnt/β-catenin signaling inhibition[J].2016,(2).
[32]Hsiao-Mei, Chao,Hong-Xuan, Huang,Po-Hsiang, Chang,etc.Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway.[J].2017,8(2).
[33]Han, Quanfa,Wang, Xiangkun,Liao, Xiwen,etc.Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus-related hepatocellular carcinoma[J].2019,42(3).
[34].Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations[J].2020,146(5).
[35]Hong-Wei, Hua,Feng, Jiang,Qian, Huang,etc.MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.[J].2015,6.
[36]Kai Jin,Hao Chen,Qisheng Zuo,etc.CREPT and p15RS regulate cell proliferation and cycling in chicken DF-1 cells through the Wnt/β-catenin pathway[J].2018,119(1).
[37]Xiaomin Fu,Jizhen Lin,Fujun Qin,etc.LncAPC drives Wnt/β-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition[J].2018,57(3).
[38]Ji-Young, Kim,Hwa-Yong, Lee,Kwan-Kyu, Park,etc.CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.[J].2016.
[39]Zhang, Lijuan,Li, Shuping,Wang, Rong,etc.Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cell by inducing mitochondrial fragmentation and activating MAPK-JNK signalling pathway[J].2019,110.
[40]Quan, Hui,Li, Bo,Yang, Jianjun.MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/beta-catenin signaling[J].2018,107.
[41]Chen, Jian,Gingold, Julian A.,Su, Xiaoping.Immunomodulatory TGF-beta Signaling in Hepatocellular Carcinoma[J].2019,25(11).
[42]Roberto Galuppo,Erin Maynard,Malay Shah,etc.Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways.[J].2014,34(4).
[43]Cao, Ningjia,Mu, Liang,Yang, Wei,etc.MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/beta-catenin signaling[J].2018,106.
[44]Valerie, Fako,Zhipeng, Yu,Curtis J, Henrich,etc.Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide.[J].2016.
[45]Fujimoto,A.,Totoki,Y.,Abe,T.,etc.Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators[J].2012,44(7).